A new case expanding the mutation and phenotype spectrum of TMEM5-related alpha-dystroglycanopathy
- 20 June 2018
- journal article
- research article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 28 (8) , 671-674
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Glycosylation with ribitol-phosphate in mammals: New insights into the O -mannosyl glycanBiochimica et Biophysica Acta (BBA) - General Subjects, 2017
- The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of DystroglycanJournal of Biological Chemistry, 2016
- TMEM5-associated dystroglycanopathy presenting with CMD and mild limb-girdle muscle involvementNeuromuscular Disorders, 2016
- Deciphering the Glycosylome of Dystroglycanopathies Using Haploid Screens for Lassa Virus EntryScience, 2013
- Identification of Mutations in TMEM5 and ISPD as a Cause of Severe Cobblestone LissencephalyThe American Journal of Human Genetics, 2012
- Fukuyama‐type congenital muscular dystrophy (FCMD) and α‐dystroglycanopathyCongenital Anomalies, 2003
- Selection of cDNAs encoding putative type II membrane proteins on the cell surface from a human full-length cDNA bankGene, 1999
- Identification and Characterization of the Dystrophin Anchoring Site on β-DystroglycanJournal of Biological Chemistry, 1995
- A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actinJournal of Cell Biology, 1993
- Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrixNature, 1992